NCT04363814View on ClinicalTrials.gov

Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection

PHASE3UnknownINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

June 10, 2020

Primary Completion Date

January 1, 2022

Study Completion Date

January 31, 2022

Conditions

COVID-19

Interventions

BIOLOGICAL

Bactek-R

BACTEK-R is a bacterial preparation that contains a mixture of Gram + and Gram - inactivated bacteria at the concentration of 300 FTU / mL (approx. 10\^9 bacteria / mL)

Trial Locations (1)

51000

Hospital Metropolitano Santiago, Santiago de los Caballeros